BOSTON - Ginkgo Bioworks Holdings Inc.  NYSE  NYSE DNA , a company specializing in cell programming and biosecurity, announced today that it expects to achieve its projected revenue and new program goals for the year ended December 31, 2023.
Ginkgo Bioworks Holdings Inc. (NYSE: DNA) expects to meet its projected revenue and new program goals for 2023.